San Jose Sharks goalie prospect Yaroslav Askarov spoke with local media for the first time Saturday at training camp.

FeedbackNow, the world leader in operational analytics for physical spaces, announced today their Series A round. The round was led by Motivate VC, Uncorrelated Ventures, and AI Growth Capital ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

For example: For all adults aged 60 and older, the societal cost per QALY saved was $196,842 for GSK's Arexvy and $176,557 for Pfizer's Abrysvo. For adults aged 65 and older, the cost was lower at ...

However, once you pick up an excellent blow dryer and one of the best round brushes, you’ll be practically unstoppable. This brush combines synthetic and boar bristle brushes and comes with ...

It is going to look a little bizarre, but there is a great reason behind the change… Nike have changed their logo on third kits to celebrate women's football. They explained their switch for ...

It plans to launch 12 new drugs by 2025, including successful new treatments like Arexvy and Ojjaara. The stock is currently trading at 9.2x forward earnings. Moreover, GSK stock offers a 3.85% ...

And that earns it the top spot in our round of the best logo maker and designer tools. As such, this makes Wix the best logo maker for beginners (or creatives in a hurry). You can change colors ...

After this, you’re asked where the logo will be used. This is great if you’re unsure about choosing the right image dimensions and resolutions (a pixelated graphic is all-round bad for business).

Scottie Scheffler moved one step closer to pocketing the $25 million payout that comes with winning the 2024 FedEx Cup Playoffs by going 65-66 over the first 36 holes to maintain his spot atop the ...

A Reddit thread started Thursday titled, "What's wrong with the Facebook logo?" shows a blue lowercase "f" on a black background instead of a blue background with a white "f." Some users who have ...

The European Commission (EC) has authorised GSK’s Arexvy for active immunisation against lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults aged 50 to ...